BARABINO SILVIA MARIA LUISA

Zerbato, B., Brancato, V., Giampà, M., Taverna, G., Monterosso, G., Taglietti, L., et al. (2025). Hexosamine Biosynthetic Pathway inhibition sensitizes pancreatic cancer cells to DNA damage. Intervento presentato a: Cancer Research Day - Syöpätutkimuspäivä 2025 - 12.3.2025, Tampere, Finland. Dettaglio

Zerbato, B., Brancato, V., Giampà, M., Taverna, G., Monterosso, G., Taglietti, L., et al. (2025). Hexosamine Pathway inhibition: one molecule able to induce a Brcaness phenotype as promising cancer therapy. Intervento presentato a: BtBs day 2025 – Giornata del Dipartimento di Biotecnologie e Bioscienze - UNIMIB, University of Milano-Bicocca, Milan, Italy. Dettaglio

Zerbato, B., Brancato, V., Giampà, M., Taverna, G., Monterosso, G., Taglietti, L., et al. (2025). PGM3 Inhibition as a Novel Strategy to Induce BRCAness in HR-Proficient Pancreatic Cancer Cells. Intervento presentato a: 17th PhD meeting TeCSBi, University of Milano-Bicocca, Milan, Italy. Dettaglio

Lombardi, S., Zilocchi, M., Nicsanu, R., Barabino, S. (2025). Emerging connections: Poly(ADP-ribose), FET proteins and RNA in the regulation of DNA damage condensates. DNA REPAIR, 150(June 2025) [10.1016/j.dnarep.2025.103846]. Dettaglio

Zerbato, B., Brancato, V., Giampà, M., Taverna, G., Monterosso, G., Taglietti, L., et al. (2025). PGM3 Inhibition as a Novel Strategy to Induce BRCAness in HR-Proficient Pancreatic Cancer Cells. Intervento presentato a: 63th SIB Congress - September 10-12, 2025, Palermo, Italy. Dettaglio